Source:http://linkedlifedata.com/resource/pubmed/id/11067930
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
2000-11-21
|
pubmed:abstractText |
The NF-kappaB family of transcription factors are involved in the regulation of innate and adaptive immune functions associated with resistance to infection. To assess the role of NF-kappaB(2) in the regulation of cell-mediated immunity, mice deficient in the NF-kappaB(2) gene (NF-kappaB(2)(-/-)) were challenged with the intracellular parasite Toxoplasma gondii. Resistance to this opportunistic pathogen is dependent on the production of IL-12, which is required for the development of innate NK cell and adaptive T cell responses dominated by the production of IFN-gamma necessary to control replication of this parasite. Although wild-type controls were resistant to T. gondii, NF-kappaB(2)(-/-) mice developed severe toxoplasmic encephalitis and succumbed to disease between 3 and 10 wk following infection. However, NF-kappaB(2) was not required for the ability of macrophages to produce IL-12 or to inhibit parasite replication and during the acute stage of infection, NF-kappaB(2)(-/-) mice had no defect in their ability to produce IL-12 or IFN-gamma and infection-induced NK cell responses appeared normal. In contrast, during the chronic phase of the infection, susceptibility of NF-kappaB(2)(-/-) mice to toxoplasmic encephalitis was associated with a reduced capacity of their splenocytes to produce IFN-gamma associated with a loss of CD4(+) and CD8(+) T cells. This loss of T cells correlated with increased levels of apoptosis and with elevated expression of the pro-apoptotic molecule Fas by T cells from infected NF-kappaB(2)(-/-) mice. Together, these results suggest a role for NF-kappaB(2) in the regulation of lymphocyte apoptosis and a unique role for this transcription factor in maintenance of T cell responses required for long-term resistance to T. gondii.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD95,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-gamma,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-12,
http://linkedlifedata.com/resource/pubmed/chemical/NF-kappa B,
http://linkedlifedata.com/resource/pubmed/chemical/NF-kappa B p52 Subunit
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0022-1767
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
165
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
5720-8
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:11067930-Animals,
pubmed-meshheading:11067930-Antigens, CD95,
pubmed-meshheading:11067930-Apoptosis,
pubmed-meshheading:11067930-Chronic Disease,
pubmed-meshheading:11067930-Cytotoxicity, Immunologic,
pubmed-meshheading:11067930-Encephalitis,
pubmed-meshheading:11067930-Female,
pubmed-meshheading:11067930-Immunity, Cellular,
pubmed-meshheading:11067930-Interferon-gamma,
pubmed-meshheading:11067930-Interleukin-12,
pubmed-meshheading:11067930-Killer Cells, Natural,
pubmed-meshheading:11067930-Lymphocyte Activation,
pubmed-meshheading:11067930-Macrophages,
pubmed-meshheading:11067930-Male,
pubmed-meshheading:11067930-Mice,
pubmed-meshheading:11067930-Mice, Inbred C57BL,
pubmed-meshheading:11067930-Mice, Inbred CBA,
pubmed-meshheading:11067930-Mice, Knockout,
pubmed-meshheading:11067930-NF-kappa B,
pubmed-meshheading:11067930-NF-kappa B p52 Subunit,
pubmed-meshheading:11067930-T-Lymphocytes,
pubmed-meshheading:11067930-Toxoplasma,
pubmed-meshheading:11067930-Toxoplasmosis, Animal,
pubmed-meshheading:11067930-Toxoplasmosis, Cerebral
|
pubmed:year |
2000
|
pubmed:articleTitle |
Identification of a role for NF-kappa B2 in the regulation of apoptosis and in maintenance of T cell-mediated immunity to Toxoplasma gondii.
|
pubmed:affiliation |
Medical Research Council Centre for Immune Regulation, School of Medicine, University of Birmingham, Edgbaston, Birmingham, United Kingdom.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|